SCHEMBL4012121

SCHEMBL4012121

CCC1CCC(NC(=O)NC2CCN(C(=O)CI)CC2)CC1

nearest known ligand 0.63

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 20/20 0.63
EPHX1 P07099 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4125958 0.83 EPHX2 (0.68) EPHX2EPHX1
SCHEMBL4010087 0.83 EPHX2 (0.64) EPHX2EPHX1
SCHEMBL4012738 0.83 EPHX2 (0.69) EPHX2EPHX1
SCHEMBL15155512 0.79 EPHX2 (0.80) EPHX2EPHX1
SCHEMBL4015826 0.79 EPHX2 (0.68) EPHX2EPHX1
SCHEMBL25934490 0.74 EPHX2 (0.44) EPHX2EPHX1
SCHEMBL4013855 0.73 EPHX1 (0.61) EPHX2EPHX1
SCHEMBL28849131 0.73 EPHX2 (0.62) EPHX2EPHX1
SCHEMBL20109074 0.73 DPP8 (0.43) EPHX2
SCHEMBL2719520 0.72 EPHX2 (1.00) EPHX2EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009086426-A2 SOLUBLE EPOXIDE HYDROLASE INHIBITORS FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION ARETE THERAPEUTICS, INC. (US) 2009-07-09 WO claimed
WO-2009086426-A2 SOLUBLE EPOXIDE HYDROLASE INHIBITORS FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION ARETE THERAPEUTICS, INC. (US) 2009-07-09 WO disclosed